ExLibris header image
SFX Logo
Title: Failure to demonstrate pluripotential hemopoietic stem cells in mouse brains.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Hoogerbrugge, P M yr:1985


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Magga, J. "Human intravenous immunoglobulin provides protection against Abeta toxicity by multiple mechanisms in a mouse model of Alzheimer's disease." Journal of neuroinflammation 7.1 (2010): 90-90. Link to Full Text for this item Link to SFX for this item
2. Klaver, Andrea C. "Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific binding." Journal of Neuroscience Methods 187.2 (2010): 263-269. Link to SFX for this item
3. Dodel, R. "Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence." Drugs 70.5 (2010): 513-528. Link to SFX for this item
4. Klaver, A C. "Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations." International immunopharmacology 10.1 (2009): 115-119. Link to SFX for this item
5. Kanninen, K. "Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease." Proceedings of the National Academy of Sciences of the United States of America 106.38 (2009): 16505-10. Link to Full Text for this item Link to SFX for this item
6. Pihlaja, R. "Transplanted Astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease." GLIA 56.2 (2008): 154-163. Link to Full Text for this item Link to SFX for this item
7. Fillit, H. "IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders." Neurology 73.3 (2009): 180-5. Link to SFX for this item
8. Ladu, A.M. J. "Abeta42 neurotoxicity in primary co-cultures: Effect of apoE isoform and Abeta conformation." Neurobiology of aging 28.8 (2006): 1139-1147. Link to SFX for this item
9. Koistinaho, M. "Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides." Nature medicine 10.7 (2004): 719-26. Link to Full Text for this item Link to SFX for this item
10. Klaver, Andrea C. "ELISA measurement of specific non-antigen-bound antibodies to Abeta1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects." Journal of neuroinflammation 8.1 (2011): 93-. Link to Full Text for this item Link to SFX for this item
11. Federici, Augusto B. "Use of Intravenous Immunoglobulin in Patients With Acquired von Willebrand Syndrome." Human immunology 66.4 (2005): 422-430. Link to SFX for this item
12. Relkin, N. "Intravenous Immunoglobulin Treatment Decreases Rates of Ventricular Enlargement and Cognitive Decline in Alzheimer's Disease." Neurology 75.4 (2010): 380-380. Link to SFX for this item
13. Eftekharzadeh, B. "Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid beta formation in NT2N neurons." Biochimie 92.3 (2010): 245-253. Link to SFX for this item
14. Scholl, M. "Time Course of Glucose Metabolism in Relation to Cognitive Performance and Postmortem Neuropathology in Met146Val PSEN1 Mutation Carriers." Journal of Alzheimer's disease 24.3 (2011): 495-506. Link to SFX for this item
15. Roher, A E E. "beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease." Proceedings of the National Academy of Sciences of the United States of America 90.22 (1993): 10836-10840. Link to Full Text for this item Link to SFX for this item
16. Robinson, Matthew M. "Acute Beta-adrenergic Stimulation does not Alter Mitochondrial Protein Synthesis or Markers of Mitochondrial Biogenesis in Adult Men." American journal of physiology. regulatory, integrative and comparative physiology 298.1 (2009): 25-33. Link to SFX for this item
17. Tobinick, E. "Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence." CNS Drugs 23.9 (2009): 713-725. Link to SFX for this item
18. Yong, Serge W. "Taking advantage of the systemic immune system to cure brain diseases." Neuron 64.1 (2009): 55-60. Link to SFX for this item
19. Domoráková, I. "Effect of Antioxidant Treatment in Global Ischemia and Ischemic Postconditioning in the Rat Hippocampus." Cellular and molecular neurobiology 29.6-7 (2009): 837-44. Link to SFX for this item
20. Malm, Tarja M. "Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice." Neurobiology of disease 18.1 (2005): 134-42. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.